SUCCESS STORIES

1. GxP Inventory Delivers Real-Time Visibility, Operational Efficiency 11/17/2025

   Modernize your clinical supply chain to streamline global trial operations, ensure regulatory compliance, and deliver investigational therapies to patients efficiently and reliably.

2. Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting 11/17/2025

   Streamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.

3. Analytics–Powered Approach To Patient Recruitment Strategy 7/15/2025

   In a Phase 3 psychiatry trial, a pharmaceutical company partnered with Signant to revolutionize patient recruitment through data-driven site selection using PureSignal Analytics.

4. Enhancing Clinical Supply Chain With Signant SmartSignals Supplies 8/16/2024

   A global pharma leader improved supply chain efficiency and compliance by digitalizing processes with Signant's SmartSignals Supplies, achieving better visibility, traceability, and reduced errors.

5. Enhancing Clinical IP Efficiency & Compliance 8/16/2024

   A U.S.-based clinical research sponsor optimized their supply chain visibility, reduced costs and risks, and improved efficiency by replacing their manual inventory management system.

6. RTSM And Clinical Drug Dispensation 7/16/2024

   A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.

7. Consolidating Clinical Supply Chain Operations With GxP Inventory 4/18/2024

   A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.

8. RTSM: Randomization And Cohort Management, IP Inventory Management 4/17/2024

   Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.

9. Unified Platform Supports Rapid Implementation Of Rescue Study 1/17/2024

   Explore how these integrated solutions helped an emerging biopharma to implement a plan for study build and migration with minimal disruption to sites.

10. Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial 1/16/2024

    Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.